Literature DB >> 8224133

Tobacco smoke exposure suppresses radiation-induced inflammation in the lung: a study of bronchoalveolar lavage and ultrastructural morphology in the rat.

L Bjermer1, Y Cai, K Nilsson, S Hellström, R Henriksson.   

Abstract

Previous studies on patients with breast cancer, who received postsurgical irradiation, displayed a markedly suppressed inflammatory response in the lung of smoking patients compared to nonsmokers. The aim of the present study was to investigate further the effect of exposure to tobacco smoke on the development of irradiation-induced pneumonitis in the rat. Four groups of animals were used: controls (C); those exposed to tobacco smoke (S); those irradiated but not exposed to smoke (RNS); and those irradiated and exposed to tobacco smoke (RS). The rats were exposed to a diluted main stream of cigarette smoke, at a concentration of about 0.4 mg.l-1, in a nose-only exposure system for 1 h.day-1, 5 days.week-1 for 10 weeks. Exposure to tobacco smoke started 3 weeks before irradiation. The basal one third of both lungs was exposed to a single radiation dose of 28 Gy (6 MeV photons). All animals were killed 7 weeks after irradiation. We compared findings in bronchoalveolar lavage (BAL) and tissue morphology. The alveolar tissue showed less inflammation in the RS-group than in the RNS-group. Most strikingly, mast cells were increased one hundredfold in the lung interstitium and thirty fold in the peribronchial area in the RNS-group, whereas no increase was found in the RS-group or in the controls. The alveolar septa of the RNS-group were thickened, with occurrence of inflammatory cells and mast cells, whereas the RS-group displayed no difference as compared to the non-irradiated, nonsmoking group (C).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224133

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

Authors:  Hekun Jin; Susan L Tucker; Hui Helen Liu; Xiong Wei; Sue Sun Yom; Shulian Wang; Ritsuko Komaki; Yuhchyau Chen; Mary K Martel; Radhe Mohan; James D Cox; Zhongxing Liao
Journal:  Radiother Oncol       Date:  2008-10-18       Impact factor: 6.280

Review 2.  Complications from Stereotactic Body Radiotherapy for Lung Cancer.

Authors:  Kylie H Kang; Christian C Okoye; Ravi B Patel; Shankar Siva; Tithi Biswas; Rodney J Ellis; Min Yao; Mitchell Machtay; Simon S Lo
Journal:  Cancers (Basel)       Date:  2015-06-15       Impact factor: 6.639

Review 3.  Radiation Pneumonitis: Old Problem, New Tricks.

Authors:  Varsha Jain; Abigail T Berman
Journal:  Cancers (Basel)       Date:  2018-07-03       Impact factor: 6.639

4.  Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers.

Authors:  Janna Berg; Christina Ramberg; Jon Olav Sulheim Haugstvedt; May-Bente Bengtson; Anne-Marie Gabrielsen; Odd Terje Brustugun; Ann Rita Halvorsen; Åslaug Helland
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

5.  Effect of EGCG on bronchial epithelial cell premalignant lesions induced by cigarette smoke and on its CYP1A1 expression.

Authors:  Qihua Gu; Fangmin Chen; Ni Chen; Jing Wang; Zhao Li; Xinhao Deng
Journal:  Int J Mol Med       Date:  2021-10-22       Impact factor: 4.101

6.  Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis.

Authors:  Yasuki Uchida; Takuya Tsugawa; Sachiko Tanaka-Mizuno; Kazuo Noma; Ken Aoki; Wataru Shigemori; Hiroaki Nakagawa; Daisuke Kinose; Masafumi Yamaguchi; Makoto Osawa; Emiko Ogawa; Yasutaka Nakano
Journal:  Radiat Oncol       Date:  2017-10-02       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.